Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease

Surgery for Crohn’s disease (CD) is not curative, as postoperative recurrence (POR) after ileocolonic resection is the rule in the absence of prophylactic treatment. In the present article, we critically review available data on the role of anti-tumour necrosis factor (TNF) agents and new biologics...

Descripción completa

Detalles Bibliográficos
Autores principales: Gisbert, Javier P., Chaparro, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462742/
https://www.ncbi.nlm.nih.gov/pubmed/37505446
http://dx.doi.org/10.1007/s40265-023-01916-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462742/
https://www.ncbi.nlm.nih.gov/pubmed/37505446
http://dx.doi.org/10.1007/s40265-023-01916-2

Ejemplares similares